ID

29055

Descripción

Ropinirole Case Report Form GSK RRL100013 GSK Study ID: 100013 Clinical Study ID: RRL100013 A 12-Week, Double-Blind, Placebo-Controlled, Twice-Daily Dosing Study to Assess the Efficacy and Safety of Ropinirole in Patients Suffering from Restless Legs Syndrome (RLS) Requiring Extended Treatment Coverage

Palabras clave

Versiones (5)
  1. 5/10/17 5/10/17 -
  2. 22/2/18 22/2/18 -
  3. 22/2/18 22/2/18 -
  4. 22/2/18 22/2/18 -
  5. 17/9/21 17/9/21 -
Titular de derechos de autor

gsk

Subido en

22 de febrero de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Ropinirole Case Report Form GSK RRL100013

Inglés

Vital signs descirptions

9 formularios  
Vital signs
Descripción

Vital signs

ADVERSE EVENTS
Descripción

Record details of any new non-serious adverse events/serious adverse events observed or reported by the subject or any changes to ongoing non-serious adverse events in the appropriate Non-Serious Adverse Events/ Serious Adverse Event section.

Tipo de datos

text

Alias
UMLS CUI [1]
C0877248
International restless legs syndrome rating scale
Descripción

International restless legs syndrome rating scale

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0449820
UMLS CUI [1,2]
C0035258
VITAL SIGNS instructions
Descripción

Semi-supine measurements must be taken first, followed straight away by the standing measurements. Blood pressure and pulse rate measurements must be recorded in both the semi-supine and standing position. Semi-supine will be defined as the subject lying flat with two pillows under his/her head. Semi-supine pulse and blood measurements will be made after the subject has been resting semi-supine for a period of at least 10 minutes. A standing blood pressure and pulse measurement will be taken after the subject has been standing for a period of one minute. Any clinically significant worsening will be recorded on the Adverse Event or SAE page of the CRF. Blood pressure measurements should not be conducted within 15 minutes of a blood sample. If the blood pressure measurement is conducted after the blood sample, you should ensure that the subject has recovered from the venepuncture before the blood pressure measurement. The blood pressure cuff must be placed on the same arm throughout the study. The same study nurse/medical professional should conduct all the blood pressure/pulse measurements for each clinic visit. Ideally, the same study nurse/medical professional should conduct all the blood pressure/pulse measurements for each patient throughout the study.

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0518766
UMLS CUI [1,2]
C1442085
Insomnia severity index
Descripción

Insomnia severity index

Tipo de datos

text

Alias
UMLS CUI [1]
C0917801
CENTRAL LABORATORY
Descripción

CENTRAL LABORATORY

Tipo de datos

text

Alias
UMLS CUI [1]
C1880016
Heart rate
Descripción

Heart rate

Tipo de datos

integer

Unidades de medida
  • bpm
Alias
UMLS CUI [1]
C0018810
bpm
Blood pressure, systolic
Descripción

Blood pressure

Tipo de datos

integer

Unidades de medida
  • mmHg
Alias
UMLS CUI [1]
C0005823
mmHg
Blood pressure, diastolic
Descripción

Blood pressure

Tipo de datos

integer

Unidades de medida
  • mmHg
Alias
UMLS CUI [1]
C0005823
mmHg
Body weight
Descripción

Body weight

Tipo de datos

float

Unidades de medida
  • kg
Alias
UMLS CUI [1]
C0005910
kg
Clinical global impression
Descripción

Clinical global impression

Tipo de datos

integer

Unidades de medida
  • cm
Alias
UMLS CUI [1]
C3639708
cm
CONCOMITANT MEDICATIONS
Descripción

Record any changes to the subject's concomitant medications or any new medications taken since the last visit in the appropriate Concomitant Medications section.

Tipo de datos

text

Alias
UMLS CUI [1]
C2347852
Volver a la parte superior de la página

Similar models

Vital signs descirptions

9 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Vital signs
ADVERSE EVENTS
Item
ADVERSE EVENTS
text
C0877248 (UMLS CUI [1])
International restless legs syndrome rating scale
Item
International restless legs syndrome rating scale
text
C0449820 (UMLS CUI [1,1])
C0035258 (UMLS CUI [1,2])
VITAL SIGNS instructions
Item
VITAL SIGNS instructions
text
C0518766 (UMLS CUI [1,1])
C1442085 (UMLS CUI [1,2])
Insomnia severity index
Item
Insomnia severity index
text
C0917801 (UMLS CUI [1])
CENTRAL LABORATORY
Item
CENTRAL LABORATORY
text
C1880016 (UMLS CUI [1])
Heart rate
Item
Heart rate
integer
C0018810 (UMLS CUI [1])
Blood pressure
Item
Blood pressure, systolic
integer
C0005823 (UMLS CUI [1])
Blood pressure
Item
Blood pressure, diastolic
integer
C0005823 (UMLS CUI [1])
Body weight
Item
Body weight
float
C0005910 (UMLS CUI [1])
Clinical global impression
Item
Clinical global impression
integer
C3639708 (UMLS CUI [1])
CONCOMITANT MEDICATIONS
Item
CONCOMITANT MEDICATIONS
text
C2347852 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial